Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,322 | -175,179 | -125,672 | -93,012 | -1,001,245 |
| Depreciation Amortization | 448,197 | 348,975 | 244,198 | 149,311 | 1,172,843 |
| Income taxes - deferred | -41,407 | -31,449 | -34,072 | -26,865 | -1,145 |
| Accounts receivable | 25,126 | 7,664 | -8,497 | -15,270 | -375 |
| Accounts payable and accrued liabilities | 11,454 | 16,256 | 19,278 | 17,356 | -10,365 |
| Other Working Capital | 1,075 | -3,026 | -27,036 | -40,490 | -36,315 |
| Other Operating Activity | 50,234 | 43,374 | 39,152 | 24,889 | 170,282 |
| Operating Cash Flow | $294,357 | $206,615 | $107,351 | $15,919 | $293,680 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 740 | 740 | -26,335 | N/A | N/A |
| PPE Investments | -127,455 | -93,136 | -61,818 | -31,585 | -124,052 |
| Net Acquisitions | -81,904 | -81,904 | -65,302 | -64,608 | N/A |
| Purchase Of Investment | -27,875 | -27,875 | N/A | -27,075 | N/A |
| Purchase Sale Intangibles | -29,569 | -29,569 | -29,569 | N/A | N/A |
| Other Investing Activity | -29,509 | -29,509 | -29,509 | 0 | 0 |
| Investing Cash Flow | $-266,003 | $-231,684 | $-182,964 | $-123,268 | $-124,052 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -550,629 | -550,629 | -550,629 | N/A | N/A |
| Common Stock Issued | 3,085 | 1,982 | 1,465 | 769 | 8,314 |
| Other Financing Activity | -4,108 | -4,109 | 0 | 0 | -2 |
| Financing Cash Flow | $-551,652 | $-552,756 | $-549,164 | $769 | $8,312 |
| Exchange Rate Effect | 6,055 | 5,747 | 6,071 | 1,585 | -3,288 |
| Beginning Cash Position | 1,298,327 | 1,298,327 | 1,298,327 | 1,298,327 | 1,123,675 |
| End Cash Position | 781,084 | 726,249 | 679,621 | 1,193,332 | 1,298,327 |
| Net Cash Flow | $-517,243 | $-572,078 | $-618,706 | $-104,995 | $174,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | 294,357 | 206,615 | 107,351 | 15,919 | 293,680 |
| Capital Expenditure | -127,455 | -93,136 | -61,818 | -31,585 | -124,052 |
| Free Cash Flow | 166,902 | 113,479 | 45,533 | -15,666 | 169,628 |